This inventor holds 1 USPTO granted patent and 3 published patent applications and 3 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Christine Wurth - Innovator in Pharmaceutical Formulations
Introduction
Christine Wurth is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of cancer. Although she currently holds no granted patents, her work is influential in the development of innovative therapies.
Latest Patent Applications
Christine Wurth's latest patent applications include:
1. **Subcutaneous HER2 Antibody Formulations** - This application presents fixed dose HER2 antibody formulations for subcutaneous administration, along with their use in cancer treatment. The formulations include fixed dose subcutaneous formulations of pertuzumab and subcutaneous co-formulations of pertuzumab and trastuzumab.
2. **Antibody Formulation** - This invention relates to a pharmaceutical formulation of a bispecific anti-VEGF/ANG2 antibody, detailing a process for the preparation and uses of the formulation.
Conclusion
Christine Wurth's innovative work in pharmaceutical formulations showcases her dedication to advancing cancer treatment. Her contributions, although not yet reflected in granted patents, highlight her potential impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile